Literature DB >> 23727924

Acidic sialidase activity is aberrant in obese and diabetic mice.

Yujin Natori1, Naoki Ohkura, Miwako Nasui, Gen-ichi Atsumi, Fumiko Kihara-Negishi.   

Abstract

Mammalian sialidases (NEU1, NEU2, NEU3 and NEU4) that remove sialic acids from glycoconjugates have been implicated in diverse cellular functions. Human sialidases are involved in the development of various disease states such as cancer, diabetes and arteriosclerosis. Unregulated acidic sialidase NEU1 activity is associated with the pathogenesis of lysosomal storage disorder (LSD) sialidosis, abnormal immune responses and cancer progression. Obesity is closely related to several chronic diseases such as diabetes, cardiovascular diseases, hyperlipidemia or hypertension that are associated with metabolic syndrome. We examined fluctuations in mRNA levels and sialidase activities of NEU1 in two strains of obese and diabetic mice to assess the involvement of NEU1 in obesity. The activity of NEU1 was preferentially higher in epididymal fat and lower in the livers of two strains of obese and diabetic mice. Fluctuations in NEU1 activity might be associated with the pathological status of these tissues in obesity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23727924     DOI: 10.1248/bpb.b12-00995

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder.

Authors:  Xu Wang; Mingyue Liu; Jifeng Zhang; Nicholas K Brown; Peng Zhang; Yan Zhang; Heng Liu; Xuexiang Du; Wei Wu; Martin Devenport; Weng Tao; Yang Mao-Draayer; Guo-Yun Chen; Y Eugene Chen; Pan Zheng; Yang Liu
Journal:  Cell Metab       Date:  2022-08-02       Impact factor: 31.373

2.  In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.

Authors:  Dario Bonardi; Viola Ravasio; Giuseppe Borsani; Alessandra d'Azzo; Roberto Bresciani; Eugenio Monti; Edoardo Giacopuzzi
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

3.  Neuraminidase 1 activates insulin receptor and reverses insulin resistance in obese mice.

Authors:  Anne Fougerat; Xuefang Pan; Victoria Smutova; Nikolaus Heveker; Christopher W Cairo; Tarik Issad; Bruno Larrivée; Jeffrey A Medin; Alexey V Pshezhetsky
Journal:  Mol Metab       Date:  2018-04-21       Impact factor: 7.422

4.  A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.

Authors:  Darrell Pilling; Tejas R Karhadkar; Richard H Gomer
Journal:  PLoS One       Date:  2020-12-30       Impact factor: 3.240

5.  Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.

Authors:  Erik P Lillehoj; Irina G Luzina; Sergei P Atamas
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

Review 6.  Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases.

Authors:  Kévin Toussaint; Aline Appert-Collin; Hamid Morjani; Camille Albrecht; Hervé Sartelet; Béatrice Romier-Crouzet; Pascal Maurice; Laurent Duca; Sébastien Blaise; Amar Bennasroune
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.